We briefly touch upon some of the available information for upcoming drugs below, both in the US and abroad: Tern Pharmaceutical (TERN): TERN-601 TERN-601 is a preclinical GLP1R agonist , which in mice has been shown to be able to reduce food intake, slow gastric emptying and improve glucose tolerance
Typically, patients may start to see changes in their weight within a few weeks of beginning Ozempic, but significant weight loss usually becomes more apparent after consistent use over several months
If weight loss plateaus for more than three to four weeks at therapeutic dose, reassess dietary intake, exercise programming, sleep quality, and stress management before attributing the plateau to the medication alone
354 GLP-1RAs and musculoskeletal health GLP-1RAs and bone The quality of bone depends on bone metabolism, and the main factors affecting bone metabolism include osteoclasts, osteoblasts, and calcitonin